Literature DB >> 10023031

Inflammation-induced changes in peripheral glutamate receptor populations.

S M Carlton1, R E Coggeshall.   

Abstract

The ionotropic glutamate receptors N-methyl-d-aspartate (NMDA), alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) and kainate (KA) have been localized on subpopulations of unmyelinated and myelinated sensory axons in normal skin. Behavioral studies indicate that activation of these receptors results in nociceptive behaviors and contributes to inflammatory pain. The goal of the present study was to determine if these glutamate receptors might contribute to the peripheral hypersensitivity observed in inflammation. The major findings were that 48 h following complete Freund's adjuvant (CFA)-induced inflammation, the proportions of unmyelinated axons labeled for NMDA, AMPA or KA receptors were 61%, 43% and 48%, respectively, in cutaneous nerves in the inflamed paw compared to 48%, 22% and 27%, respectively, in the non-inflamed paw. The proportions of myelinated axons labeled for NMDA, AMPA or KA receptors were 61%, 61% and 43%, respectively, compared to 43%, 42% and 28%, respectively, in the non-inflamed hindpaw. These increases were all significant. These data indicate that the number of sensory axons containing ionotropic glutamate receptors increases during inflammation, and this may be a contributing factor to peripheral sensitization in inflammation. Copyright 1999 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10023031     DOI: 10.1016/s0006-8993(98)01328-6

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  38 in total

Review 1.  Glutamate pharmacology and metabolism in peripheral primary afferents: physiological and pathophysiological mechanisms.

Authors:  Kenneth E Miller; E Matthew Hoffman; Mathura Sutharshan; Ruben Schechter
Journal:  Pharmacol Ther       Date:  2011-01-26       Impact factor: 12.310

2.  Potentiation of mouse vagal afferent mechanosensitivity by ionotropic and metabotropic glutamate receptors.

Authors:  James A Slattery; Amanda J Page; Camilla L Dorian; Stuart M Brierley; L Ashley Blackshaw
Journal:  J Physiol       Date:  2006-08-31       Impact factor: 5.182

3.  Opioid tolerance development: a pharmacokinetic/pharmacodynamic perspective.

Authors:  Emily O Dumas; Gary M Pollack
Journal:  AAPS J       Date:  2008-11-07       Impact factor: 4.009

4.  Expression of Glutaminase and Vesicular Glutamate Transporter Type 2 Immunoreactivity in Rat Sacral Dorsal Root Ganglia Following a Surgical Tail Incision.

Authors:  Heith A Crosby; Michael Ihnat; Diana Spencer; Kenneth E Miller
Journal:  Pharm Pharmacol Int J       Date:  2015-06-16

Review 5.  Ionotropic glutamate receptors in spinal nociceptive processing.

Authors:  Max Larsson
Journal:  Mol Neurobiol       Date:  2009-10-31       Impact factor: 5.590

Review 6.  Kainate receptor signaling in pain pathways.

Authors:  Sonia K Bhangoo; Geoffrey T Swanson
Journal:  Mol Pharmacol       Date:  2012-10-24       Impact factor: 4.436

7.  Intrathecal injection of GluR6 antisense oligodeoxynucleotides alleviates acute inflammatory pain of rectum in rats.

Authors:  Wei-Guang Zhang; Li-Cai Zhang; Zhen-Dan Peng; Yin-Ming Zeng
Journal:  Neurosci Bull       Date:  2009-10       Impact factor: 5.203

8.  Gargling with ketamine attenuates the postoperative sore throat.

Authors:  A Rudra; Suchanda Ray; S Chatterjee; A Ahmed; S Ghosh
Journal:  Indian J Anaesth       Date:  2009-02

Review 9.  Targeting the NMDA receptor subunit NR2B for the treatment of neuropathic pain.

Authors:  Long-Jun Wu; Min Zhuo
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

10.  Intradermal administration of magnesium sulphate and magnesium chloride produces hypesthesia to mechanical but hyperalgesia to heat stimuli in humans.

Authors:  Takahiro Ushida; Osamu Iwatsu; Kazuhiro Shimo; Tomoko Tetsunaga; Masahiko Ikeuchi; Tatsunori Ikemoto; Young-Chang P Arai; Katsutoshi Suetomi; Makoto Nishihara
Journal:  J Neuroinflammation       Date:  2009-08-28       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.